ORGENESIS INC (ORGS)

Sector:
INDUSTRIALS
Industry:
COMMERCIAL SERVICES & SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vered Caplan
Employees:
150
20271 GOLDENROD LANE, GERMANTOWN, MD 20876
(480) 659-6404

The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics. It focuses on autologous therapies, with processes and systems that are developed for each therapy.

Data derived from most recent annual or quarterly report
Market Cap 62.546 Million Shares Outstanding24.82 Million Avg 30-day Volume 34.575 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.43
Price to Revenue1.2383 Debt to Equity0.1706 EBITDA-10.596 Million
Price to Book Value1.2007 Operating Margin-50.694700000000005 Enterprise Value35.269 Million
Current Ratio0.932 EPS Growth0 Quick Ratio0.783
1 Yr BETA 0.8892 52-week High/Low 4.04 / 1.13 Profit Margin-54.3304
Operating Cash Flow Growth76.1206 Altman Z-Score-1.9924 Free Cash Flow to Firm -85 Thousand
Earnings Report2023-03-30
View SEC Filings from ORGS instead.

View recent insider trading info

Funds Holding ORGS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORGS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-01-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-12-19:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-17:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-15:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SIDRANSKY DAVID

    • Director
    20,450 2022-12-23 1

    ADLER YARON

    • Director
    15,000 2022-12-23 1

    PHILIPS MARIO

    • Director
    13,750 2022-12-23 1

    YACHIN GUY

    • Director
    19,600 2022-12-23 1

    NANDA ASHISH

    • Director
    15,850 2022-12-23 1

    CAPLAN VERED CEO AND CHAIRMAN

    • Officer
    • Director
    85,000 2022-06-14 2

    REITHINGER NEIL CFO, TREASURER AND SECRETARY

    • Officer
    15,000 2022-06-14 1

    ASSA KUNIK EFRAT CHIEF DEVELOPMENT OFFICER

    • Officer
    15,000 2022-06-14 1

    FERBER SARAH CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2020-03-19 0

    BEDORET DENIS SEE REMARKS

    • Officer
    0 2018-05-14 0

    UNIVERSITE LIBRE DE BRUXELLES

    • LESS THAN 10%
    No longer subject to file 2017-11-13 0

    THEODORUS II SA

    • LESS THAN 10%
    No longer subject to file 2017-10-11 0

    THEODORUS SCA

    • LESS THAN 10%
    No longer subject to file 2017-10-11 0

    BELENGER OLIVIER

    • LESS THAN 10%
    No longer subject to file 2017-10-11 0

    SHVARTZ ODED

    • 10% Owner
    21,967,890 2015-08-07 0

    BULTOT HUGUES

    • Director
    12,177,544 2015-06-18 0

    BUYSE CHRIS GEORGES FRANS

    • Director
    0 2015-03-02 0

    TENNE JOSEPH CFO TREASURER SECRETARY

    • Officer
    0 2014-04-16 0

    DIPASQUALE SAV PRESIDENT AND CEO

    • Officer
    0 2012-12-17 0

    HANOCHI ETTI

    • Director
    0 2012-08-07 0

    WEINBERG DOV CFO, SECRETARY & TREASURER

    • Officer
    0 2012-02-02 0

    BENAIRIE JACOB PRESIDENT & CEO

    • Officer
    0 2012-02-02 0

    CUISON GILBERT ADRIAS PRESIDENT & SECRETARY

    • Officer
    • Director
    • 10% Owner
    1,445,129 2011-06-28 0

    GOLEZ JEROME PERALTA TREASURER

    • Officer
    • Director
    • 10% Owner
    1,445,129 2011-06-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ADLER YARON - Director

    2022-12-29 09:25:06 -0500 2022-12-23 A 15,000 a 15,000 direct

    NANDA ASHISH - Director

    2022-12-29 09:27:14 -0500 2022-12-23 A 15,850 a 15,850 direct

    PHILIPS MARIO - Director

    2022-12-29 09:29:21 -0500 2022-12-23 A 13,750 a 13,750 direct

    SIDRANSKY DAVID - Director

    2022-12-29 09:31:45 -0500 2022-12-23 A 20,450 a 20,450 direct

    YACHIN GUY - Director

    2022-12-29 09:33:29 -0500 2022-12-23 A 19,600 a 19,600 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ORGENESIS INC ORGS 2023-01-26 22:15:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 21:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 21:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 20:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 20:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 19:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 19:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 18:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 18:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 17:45:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 17:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 16:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 16:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 15:45:03 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 15:15:04 UTC -3.4736 7.7936 750000
    ORGENESIS INC ORGS 2023-01-26 14:45:04 UTC 2.1949 2.1251 750000
    ORGENESIS INC ORGS 2023-01-26 14:15:03 UTC 2.1949 2.1251 750000
    ORGENESIS INC ORGS 2023-01-26 13:45:03 UTC 2.1949 2.1251 750000
    ORGENESIS INC ORGS 2023-01-26 13:15:04 UTC 2.1949 2.1251 750000
    ORGENESIS INC ORGS 2023-01-26 12:45:04 UTC 2.1949 2.1251 750000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments